Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 19, 2026.

Predictors of adherence to exercise interventions during and after cancer treatment: A systematic review

H.L. Ormel, G.G.F. van der Schoot, W.J. Sluiter and 3 more

Psycho-Oncology · 2018 · Systematic review · CC BY

doi:10.1002/pon.4612

Abstract

Objective. Exercise interventions benefit cancer patients. However, only low numbers of patients adhere to these interventions. This review aimed to identify predictors of exercise intervention adherence in patients with cancer, during and after multimodality cancer treatment.

Methods. A literature search was performed using electronic databases (PubMed, Embase, and Cochrane) to identify relevant papers published before February 1, 2017. Papers reporting randomized controlled trials, conducted in adult cancer patients who participated in an exercise intervention during and/or after multimodality cancer treatment, and providing outcome of factors predicting exercise adherence were included. Papers were assessed for methodological quality by using the Physiotherapy Evidence Database scale.

Results. The search identified 720 potentially relevant papers, of which 15 fulfilled the eligibility criteria. In these 15 studies, 2279 patients were included and 1383 of these patients were randomized to an exercise intervention. During cancer treatment, the factors predicting exercise adherence were as follows: location of the rehabilitation center, extensive exercise history, high motivation for exercise, and fewer exercise limitations. After cancer treatment, factors that predicted adherence were as follows: less extensive surgery, low alcohol consumption, high previous exercise adherence, family support, feedback by trainers, and knowledge and skills of exercise. Methodological quality of the included papers was rated “high”.

Conclusions. The most prominent predictors of adherence to exercise interventions were location of the rehabilitation center, extensive exercise history, high motivation for exercise, and fewer exercise limitations. To increase the number of cancer patients who will benefit, these results should be considered into the development and implementation of future exercise interventions.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 20, 2026. Paragraph numbers are ours, so an answer can point at one.

INTRODUCTION

Cancer affects millions of people worldwide, and in 2012, the reported incidence was 14.1 million.1 Earlier and more accurate cancer diagnosis in combination with better treatments have improved cancer survival.2, 3, 4 Over the last 2 decades, survival rates have increased significantly. In the United States alone, there were more than 14 million cancer survivors and these numbers are expected to increase up to an estimated 18 million in 2020.2, 3

Increasingly, depending on cancer type, stage, and (genetic) characteristics, patients receive multimodality cancer treatment, often including surgery, radiotherapy, and/or systemic treatment.5 Cancer treatment can result in deterioration of physical fitness, decreased muscle strength, fatigue, and a reduced quality of life.6, 7, 8 Cancer treatment can also result in inactivity and weight gain, as previously described in patients diagnosed with breast cancer, prostate cancer, testicular cancer, and leukemia.9, 10, 11 Moreover, cancer survivors frequently experience long‐term adverse events related to the cancer treatment such as the development of metabolic syndrome and subsequent cardiovascular disease.12, 13, 14

Evidence is accumulating that physical exercise complementary to cancer treatment is safe and feasible.15, 16 Encouraging effects of exercise interventions to improve lifestyle in patients with various cancer diagnoses have been reported.15, 17, 18 In general, exercise interventions can alleviate common side effects of cancer treatment, for example, by increasing patients' physical fitness, improving quality of life, and reducing cancer‐related fatigue.6, 7, 17, 19 In patients diagnosed with lymphoma, breast cancer, colorectal cancer, or prostate cancer, physical exercise may be associated with improved progression‐free survival.20, 21, 22 Importantly, an increase in physical exercise behavior and maintenance of this behavior after completion of cancer treatment may lower the risk of cancer recurrence, as reported in patients diagnosed with breast or prostate cancer.23, 24 In various cancer types, physical exercise appears to decrease disease‐related morbidity and mortality.24, 25, 26, 27 A meta‐analysis of 23 prospective studies in breast and colorectal cancer survivors found that engaging in at least 150 minutes of moderate to vigorous intensity physical exercise was associated with a reduction in the risk of overall mortality of approximately 24% compared to being less physically active.24 These benefits are comparable to the effect of smoking cessation on reducing the risk of cancer mortality.28

Behavioral change, focused on adaption of a healthier lifestyle, is complicated. A cancer diagnosis and subsequent treatment may potentially motivate patients to change their lifestyle (eg, to become more active, follow a healthier diet, or quit smoking).29, 30, 31 In observational studies, however, a decrease in patients' physical exercise frequency was found after being diagnosed with breast cancer and this effect was more distinct in obese, sedentary, and elderly patients.32, 33

Accumulating data on the negative effects of being overweight on the development of cancer and cancer survival fuel the sense of urgency for successful interventions to enhance a healthy lifestyle.8, 21, 34 Unfortunately, low adherence to the interventions and limited recruitment rates are frequently reported in studies investigating exercise interventions in cancer patients, both during and after cancer treatment.35, 36 Several barriers to physical exercise (eg, fatigue, time restraints, and discomfort) have been reported.35, 37, 38 Understanding which factors predict adherence to exercise interventions is essential to identify patients that are intending to increase their physical exercise intensity but who are at risk of nonadherence. Identifying predictors of exercise adherence can contribute to an increased number of cancer patients participating in exercise interventions, with potential benefits in cancer outcome.36, 39

The aim of this review is to identify predictors of adherence to exercise interventions in patients with cancer, during and after multimodality cancer treatment. This knowledge will help optimize implementation strategies and eventually help in improving cancer treatment outcome.

Design

A systematic review was performed to identify predictors of adherence to exercise interventions from randomized controlled trials (RCTs) and to discuss the methodological quality and results of included papers. This systematic review was conducted in accordance with Preferred Reporting Items of Systematic Reviews and Meta‐Analyses (PRISMA) guidelines.40

Literature search

A literature search was performed using electronic databases (PubMed, Embase, and Cochrane) to identify relevant paper published before February 1, 2017. The complete search including Medical Subject Headings (MeSH) terms and keywords is described in Tables S1 and S2. In addition, reference tracking of all papers was performed. Full papers were eligible for inclusion when they reported an RCT design, were conducted in adult cancer patients who participated in a physical exercise intervention during or after systemic (neo‐) adjuvant cancer treatment, provided outcome of factors predicting exercise intervention adherence, and were written in English. An exercise intervention was defined as exercise interventions involving any physical movement produced by skeletal muscles that require energy expenditure41; that were planned, structured, and repetitive; that were of at least moderate to vigorous intensity; and that were aimed to improve or maintain physical fitness over a predetermined time period.42 Pilot studies, case studies, and papers of low methodological quality were not included.

Selection of studies

Selected papers were screened based on title and abstract. In cases when titles and abstracts implied that a paper was potentially eligible for inclusion, a full paper copy of the report was obtained and evaluated for inclusion.

Data extraction and assessment of methodological quality

Data were extracted using a predetermined extraction form and in accordance with PRISMA guidelines.40 Data extracted were as follows: (1) first author's last name, year of publication, country, and trial name; (2) design; (3) population (number of participants, gender, age, cancer type(s), stage, and treatment modalities); (4) exercise intervention (extent, duration, type, frequency, treatment phase, intensity, adherence facilitation, and control group program); (5) outcome (outcome measures of adherence and measurement instruments); (6) results (adherence rate, univariable and multivariable analysis, and variance in exercise intervention adherence explained by analyzed factors (R2 or area under the curve [AUC]). Two investigators conducted the search and data extraction in collaboration (G.S. and H.O.). The two investigators scored the methodological quality of included papers independently (G.S. and H.O.) using the Physiotherapy Evidence Database (PEDro) scale.43 The scale is composed of 11 items, of which the first item is only applicable for specification of eligibility criteria and is not considered as part of calculating the overall PEDro score. Studies scored one point for each item present and could score between 0 to 10 points. Studies that scored ≥4 points were classified as “high” quality and studies that scored <4 points were considered to be of “low” methodological quality.44 Disagreement between the 2 investigators regarding a papers' quality score was resolved by discussion with a third investigator (A.W.) until consensus was reached. Cohen's Kappa and percentage of agreement on methodological quality were calculated.

Selection of studies

The primary search strategy identified 720 potentially relevant papers, of which 502 remained after discarding duplicates (Figure 1). After screening based on title and abstract, 30 papers were potentially eligible for inclusion. Fifteen of these papers met predefined eligibility criteria, of which the oldest paper was published in 2002.45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59

Characteristics of included studies

In total, 2279 cancer patients were included in the 15 studies analyzed.45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59 Of these patients, 1383 were assigned to an exercise intervention and these patients had a mean age of 55.5 years. All studies used an RCT design and were conducted in the United States, Canada, Australia, the Netherlands, Germany, or Taiwan. Eligibility criteria were heterogeneous among studies, with differences in cancer type(s), cancer treatment phase, exercise interventions, and patient characteristics. A full description of the different study characteristics is depicted in Table 1.

Applied timing of exercise interventions varied. Five studies applied their exercise intervention after systemic (neo‐) adjuvant treatment,50, 51, 52, 53, 54 5 studies both during and after treatment,55, 56, 57, 58, 59 and 5 studies during treatment.45, 46, 47, 48, 49 Furthermore, 4 studies included a population with multiple cancer types,49, 52, 55, 59 whereas 11 other studies included a single cancer type population.45, 46, 47, 48, 50, 51, 53, 54, 56, 57, 58 Six of the 15 studies included only patients diagnosed with breast cancer,45, 46, 47, 51, 53, 54 2 studies included patients with prostate cancer,48, 56 1 study included patients with head and neck cancer,50 1 study included patients with lymphoma,57 and 1 study included patients with colorectal cancer.58

In 5 studies, the exercise intervention was performed at a rehabilitation center (center based)46, 47, 48, 50, 57; in 6 studies, the intervention was performed at the patient's home (home based)49, 52, 53, 54, 58, 59; and 4 studies conducted their intervention in both settings.45, 51, 55, 56 Duration of exercise interventions ranged from 5 weeks to 24 months. Various physical exercise modalities were used in the selected studies: aerobic (brisk walking, cycling, treadmill, or swimming),53, 54, 57, 58, 59 strength (resistance, stretching, and postural exercises),48, 50, 51 or combined aerobic and strength exercises.45, 46, 47, 49, 52, 55, 56

Intensity of the exercise interventions differed from low to high (high intensity in terms of exercise sessions that were more frequent, of longer duration or with a higher peak oxygen uptake [VO2 peak percentage]). All studies conducted the exercise interventions with progressive intensity, and in nearly all studies, physiotherapists or exercise physiologists tailored the exercise interventions to the patient's health by modifying exercise prescriptions. Additionally, patients' adherence to exercise was facilitated in all studies.

Assessment of methodological quality and quantitative analysis

The 15 included studies were scored using the PEDro scale. The 2 investigators (G.S. and H.O.) agreed on 147 of the maximal 160 points (91.9%). Kappa statistics calculated for agreement of the methodological quality assessment between the 2 investigators was 0.82, corresponding with an excellent agreement. Methodological quality ranged from 4 to 8 as rated on the PEDro scale with a median score of 7 of 10, confirming “high” methodological quality. All studies were rated as high qualitative studies45, 46, 47, 48, 49, 50, 52, 53, 54, 55, 56, 57, 58, 59 with a score of ≥4, of which 6 scored 8 of 10 points.48, 50, 52, 53, 58, 59 The methodological quality assessment is summarized in Table 2. Unfortunately, a quantitative analysis by pooling outcome data (meta‐analysis) or a best‐evidence synthesis was inappropriate. This is due to incomparability of outcome data caused by heterogeneity of study sample characteristics (eg, divergent exercise interventions, patient characteristics, and outcome as summarized in Table 1).

Measurement instruments and outcome measures of adherence

In 7 studies, adherence to exercise intervention was measured using an exercise log.45, 49, 51, 52, 53, 54, 55 In 2 studies, patients used a pedometer to measure adherence.49, 54 Seven studies assessed adherence through recording of attended exercise intervention sessions.45, 46, 47, 48, 50, 56, 57 An alternative instrument to record adherence, applied by 2 studies, was the leisure score index.58, 59 One study assessed adherence by verifying whether patients met their weekly exercise goals54 (Table 1).

Outcome of adherence to exercise intervention was defined by 7 studies as percentage of scheduled minutes of weekly moderate to vigorous physical exercise.45, 52, 53, 54, 55, 58, 59 Ten studies defined exercise intervention adherence as number or percentage of attended exercise sessions.45, 46, 47, 48, 49, 50, 51, 52, 56, 57 Two studies defined adherence as a number of steps per week.49, 54 One study defined adherence as meeting the weekly exercise goal(s).54 One study defined adherence as percentage of prescribed intensity, frequency, and duration of the multimodal (resistance and aerobic) exercise intervention52 (Table 1).

Univariable and multivariable analyses of selected studies

A wide range of predictive factors were investigated, which were classified as socio‐demographic (eg, gender, marital status, education, employment, location of the rehabilitation center in relation to the residential area, family support, and feedback by trainers), medical (eg, cancer type, treatment regimen, pretreatment fatigue, and disease stage), physical and physiological (eg, physical fitness and body mass index) and behavioral factors (eg, exercise history, baseline self‐efficacy, exercise motivation, smoking behavior, and alcohol consumption). Study results are depicted in Tables 3 and S3.

Highly significant (P ≤.01) and significant (P <.05) or borderline significant (P <.10) associations between exercise intervention adherence and various factors were identified in univariable45, 46, 47, 48, 50, 52, 53, 55, 56, 57, 58, 59 or bivariable analysis.49, 51 Thereafter, these factors were included in a multivariable analysis to finally derive predictors of adherence to exercise intervention. One study did not describe a univariable or bivariable analysis.54 An overview of the significant predictors of adherence to exercise interventions during and after cancer treatment is summarized in Table 3. Adherence rates ranged from 61.9% to 91.0%. The R2, defined as the percentage of variance explained by the model, was reported in 9 studies46, 47, 48, 49, 50, 51, 55, 57, 58, 59 and ranged from 20.4% to 75.0%. One study described the fit of the multivariable model by calculating the area under the curve, with reported values52 of 0.67 to 0.75. Data and P values of univariable and multivariable analyses are summarized in Table S3. All factors gathered in multivariable analysis in each study were summarized and weighted as a predictor of exercise adherence. Factors found in the multivariable analyses that significantly predicted adherence to exercise intervention in cancer patients during and after cancer treatment are presented in Table 3.

DISCUSSION

This review summarizes predictors of adherence to exercise intervention by patients during and after multimodality cancer treatment. Adherence to exercise interventions varies among trials.50, 51, 52, 53 Insight in factors determining adherence can optimize exercise intervention implementation strategies and eventually improve cancer treatment outcome. The most important result is that adherence to exercise depends on different factors during different stages of cancer treatment and in different cancer types. More specifically, medical factors predicting low adherence to exercise interventions during treatment include advanced disease stage, extensive treatment protocols, and exercise limitations due to cancer treatment (Table 3). Factors predicting high adherence to the exercise intervention after treatment include socio‐demographic, physical, physiological, and behavioral factors; more family support and feedback by trainers, physical fitness, high self‐efficacy, high motivation to exercise and being a non‐smoker. To enhance adherence to exercise interventions during and after treatment, it would be most beneficial to address behavioral factors and socio‐demographic factors.60 Examples include providing exercise interventions close to the patient's home, stimulating family support and increasing exercise motivation by improving feedback and coaching by trainers.

The location of the rehabilitation center contributes highly in predicting adherence to center‐based exercise interventions during chemotherapy in breast cancer patients, as described by 2 studies of Courneya et al.46, 47 Reduced travel distance between the residential area and rehabilitation center was previously identified as a predictor of better adherence to exercise intervention in pediatric patients diagnosed with cancer.61 Likewise, prolonged travel distance was found to be a predictor of worse adherence to a supervised exercise intervention in patients with chronic obstructive pulmonary disease who were rehabilitated in an 8‐week supervised exercise intervention.62 Participation in exercise interventions is time‐consuming, especially when patients rely on public transportation for travelling to the exercise location.63 Travel distance not only negatively influences exercise adherence, it is often a reason to not participate in center‐based exercise interventions.47, 61 Albornoz et al highly recommend distribution of treatment locations throughout the country and thus near patients' homes.64

Home‐based exercise interventions, in which patients can exercise individually, could offer a convenient solution and may be preferred by certain groups of patients, eg, when travel distances are long.65, 66 However, a disadvantage of these home‐based interventions is that control of exercise adherence is suboptimal. Supervision or coaching in the home‐based setting is based on enhancing exercise adherence by stimulating family support and feedback by physiotherapists and improving exercise knowledge and skills of exercise.46, 67 In addition, upcoming technological developments, eg, tools such as wearable activity trackers and mobile applications, facilitate objective monitoring of patients' exercise adherence in home‐based settings.68 These tools can measure and record exercise levels, which can help monitor patients' physical exercise behavior after completing a supervised exercise intervention.25

Higher willingness to change physical exercise behavior, ie, exercise motivation, was a significant predictor in 4 of the included studies.48, 53, 58, 59 This is in line with the meta‐analysis performed by Husebø et al, in which a significant association between exercise motivation and exercise intervention adherence was described.69 Exercise motivation is measured by the transtheoretical model stage of behavior change, one of many behavioral models used in exercise motivation.70 This model describes motivational processes involved in attempting to change physical exercise behavior, including the stages of precontemplation, contemplation, preparation, action, and maintenance. According to the meta‐analysis performed by Marshall et al, transition from the precontemplation phase (sedentary, no intention) to the contemplation phase (sedentary, intention within 6 mo) may especially contribute to a change in behavior.71 This result suggests that facilitating behavioral change after cancer diagnosis could result in improved exercise adherence. However, behavioral factors are more crucial in predicting exercise adherence in unsupervised exercise compared to supervised interventions.47

Awareness of the importance of physical exercise not only in cancer treatment but also in other chronic diseases, such as chronic obstructive pulmonary disease and diabetes, has increased over the past years.72, 73 Consequently, the number of RCTs investigating exercise interventions during and after cancer treatment has increased. However, data on predictors of adherence to the exercise intervention are often not described in these RCTs, particularly in those performed in a home‐based setting.74

One of the strengths of this systematic review is that all studies were of “high” methodological quality. This is in contrast to methodological quality assessment of a previous systematic review, assessing determinants of exercise adherence and maintenance.75 This difference may be due to the use of a methodological quality assessment tool that was adapted from existing quality criteria lists compiled by Kampshoff et al,75 whereas we pursued the PRISMA guidelines for reporting systematic reviews and used the PEDro scale, which is especially designed for assessment of clinical trials.40, 43 The internal validity of our review is partially warranted by limiting the inclusion to randomized studies.76

A systematic review by Husebø et al demonstrated that several psychological factors predicted exercise intervention adherence. However, socio‐demographic, medical or physical, and physiological factors were not investigated.69 In contrast, our review indicated that psychological factors only partially predicted exercise intervention adherence and suggest a more important role for socio‐demographic, medical or physical, and physiological factors, such as fewer exercise limitations due to cancer treatment, pretreatment fatigue or high VO2 peak levels.

Study limitations

A limitation of our review was the relatively low number of RCTs included despite the extensive literature search. Few RCTs that investigated predictors of exercise intervention adherence during and after cancer treatment and met our inclusion criteria were identified. Grey literature was not considered in the literature search. The possibility that an RCT fulfilling our inclusion and exclusion criteria was conducted but not reported in the scientific literature was estimated to be very small. We were unable to perform a quantitative analysis or a best‐evidence synthesis, due to the heterogeneity of the data.

Clinical implications and conclusions

In summary, recommendations for future trials include the use of equivalent measuring instruments in future RCTs to facilitate a more homogeneous analysis across studies. We recommend future RCTs to report predictors of exercise intervention adherence and to use objective measurement instruments such as attendance records and validated wearable activity trackers (eg, accelerometers). This facilitates the comparison of studies investigating predictors of exercise intervention adherence during and after multimodality cancer treatment.74 Hence, the power of generated data in the field of exercise oncology will increase. Furthermore, we recommend the analysis and reporting of potential preexistent factors that may impede adherence to and participation in an exercise intervention in clinical practice. In this manner, patients less likely to adhere can be offered a personalized exercise intervention and extra guidance, by means of, eg, prolonged coaching to facilitate exercise adherence.77, 78 These approaches might result in optimizing participation in exercise interventions and retaining the less motivated, less fit patients who will potentially benefit most.25 Since it is increasingly recognized that exercise interventions should be included in the treatment of cancer patients, predictors of exercise intervention adherence should be taken into account when composing these interventions.

CONFLICT OF INTEREST

The authors have no funding or conflicts of interest to disclose.

ETHICS APPROVAL

As a systematic review, no ethical approval was sought for this article.

References 78

  1. 1.

    Torre LA, Bray F, Siegel RL, Ferlay J, Lortet‐Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87‐108.

    Not in our library10.3322/caac.21262

  2. 2.

    Ballard‐Barbash R, Friedenreich CM, Courneya KS, Siddiqi SM, McTiernan A, Alfano CM. Physical activity, biomarkers, and disease outcomes in cancer survivors: A systematic review. J Natl Cancer Inst. 2012;104(11):815‐840.

    Not in our library10.1093/jnci/djs207

  3. 3.

    Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5‐29.

    Not in our library10.3322/caac.21254

  4. 4.

    Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69‐90.

    Not in our library10.3322/caac.20107

  5. 5.

    Duffy MJ, Crown J. A personalized approach to cancer treatment: How biomarkers can help. Clin Chem. 2008;54(11):1770‐1779.

    Not in our library10.1373/clinchem.2008.110056

  6. 6.

    Velthuis MJ, Agasi‐Idenburg SC, Aufdemkampe G, Wittink HM. The effect of physical exercise on cancer‐related fatigue during cancer treatment: A meta‐analysis of randomised controlled trials. Clin Oncol. 2010;22(3):208‐221.

    Not in our library10.1016/j.clon.2009.12.005

  7. 7.

    Speed‐Andrews AE, Courneya KS. Effects of exercise on quality of life and prognosis in cancer survivors. Curr Sports Med Rep. 2009;8(4):176‐181.

    Not in our library10.1249/jsr.0b013e3181ae98f3

  8. 8.

    Chlebowski RT. Weight loss in breast cancer patient management. J Clin Oncol. 2002;20(4):1128‐1143.

    Not in our library10.1200/jco.2002.20.4.1128

  9. 9.

    de Haas EC, Altena R, Boezen HM, et al. Early development of the metabolic syndrome after chemotherapy for testicular cancer. Ann Oncol. 2013;24(3):749‐755.

    Not in our library10.1093/annonc/mds527

  10. 10.

    Dieli‐Conwright CM, Wong L, Waliany S, Bernstein L, Salehian B, Mortimer JE. An observational study to examine changes in metabolic syndrome components in patients with breast cancer receiving neoadjuvant or adjuvant chemotherapy. Cancer. 2016;122(17):2646‐2653.

    Not in our library10.1002/cncr.30104

  11. 11.

    de Haas EC, Oosting SF, Lefrandt JD, Wolffenbuttel BH, Sleijfer DT, Gietema JA. The metabolic syndrome in cancer survivors. Lancet Oncol. 2010;11(2):193‐203.

    Not in our library10.1016/s1470-2045(09)70287-6

  12. 12.

    Aleman BMP, Moser EC, Nuver J, et al. Cardiovascular disease after cancer therapy. Eur J Cancer Suppl. 2014;12(1):18‐28.

    Not in our library10.1016/j.ejcsup.2014.03.002

  13. 13.

    Haugnes HS, Bosl GJ, Boer H, et al. Long‐term and late effects of germ cell testicular cancer treatment and implications for follow‐up. J Clin Oncol. 2012;30(30):3752‐3763.

    Not in our library10.1200/jco.2012.43.4431

  14. 14.

    Boer H, Proost JH, Nuver J, et al. Long‐term exposure to circulating platinum is associated with late effects of treatment in testicular cancer survivors. Ann Oncol. 2015;26(11):2305‐2310.

    Not in our library10.1093/annonc/mdv369

  15. 15.

    Jones LW, Alfano CM. Exercise‐oncology research: past, present, and future. Acta Oncol (Madr). 2013;52(2):195‐215.

    Not in our library10.3109/0284186x.2012.742564

  16. 16.

    Courneya KS, Sellar CM, Stevinson C, et al. Randomized controlled trial of the effects of aerobic exercise on physical functioning and quality of life in lymphoma patients. J Clin Oncol. 2009;27(27):4605‐4612.

    Not in our library10.1200/jco.2008.20.0634

  17. 17.

    Knols R, Aaronson NK, Uebelhart D, Fransen J, Aufdemkampe G. Physical exercise in cancer patients during and after medical treatment: A systematic review of randomized and controlled clinical trials. J Clin Oncol. 2005;23(16):3830‐3842.

    Not in our library10.1200/jco.2005.02.148

  18. 18.

    Courneya KS, McKenzie DC, Mackey JR, et al. Effects of exercise dose and type during breast cancer chemotherapy: Multicenter randomized trial. J Natl Cancer Inst. 2013;105(23):1821‐1832.

    Not in our library10.1093/jnci/djt297

  19. 19.

    Irwin ML, Cartmel B, Gross CP, et al. Randomized exercise trial of aromatase inhibitor‐induced arthralgia in breast cancer survivors. J Clin Oncol. 2015;33(10):1104‐1111.

    Not in our library10.1200/jco.2014.57.1547

  20. 20.

    Courneya KS, Friedenreich CM, Franco‐Villalobos C, et al. Effects of supervised exercise on progression‐free survival in lymphoma patients: An exploratory follow‐up of the HELP trial. Cancer Causes Control. 2015;26(2):269‐276.

    Not in our library10.1007/s10552-014-0508-x

  21. 21.

    Meyerhardt JA, Giovannucci EL, Holmes MD, et al. Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol. 2006;24(22):3527‐3534.

    Not in our library10.1200/jco.2006.06.0855

  22. 22.

    Schmidt ME, Chang‐Claude J, Vrieling A, et al. Association of pre‐diagnosis physical activity with recurrence and mortality among women with breast cancer. Int J Cancer. 2013;133(6):1431‐1440.

    Not in our library10.1002/ijc.28130

  23. 23.

    Bonn SE, Sjolander A, Lagerros YT, et al. Physical activity and survival among men diagnosed with prostate cancer. Cancer Epidemiol Biomarkers Prev. 2015;24(1):57‐64.

    Not in our library10.1158/1055-9965.epi-14-0707

  24. 24.

    Schmid D, Leitzmann MF. Association between physical activity and mortality among breast cancer and colorectal cancer survivors: A systematic review and meta‐analysis. Ann Oncol. 2014;25(7):1293‐1311.

    Not in our library10.1093/annonc/mdu012

  25. 25.
  26. 26.

    Schmid D, Leitzmann MF. Cardiorespiratory fitness as predictor of cancer mortality: A systematic review and meta‐analysis. Ann Oncol. 2015;26(2):272‐278.

    Not in our library10.1093/annonc/mdu250

  27. 27.

    Moore SC, Lee I‐M, Weiderpass E et al. Association of leisure‐time physical activity with risk of 26 types of cancer in 1.44 million adults. JAMA Intern Med 2016;176(6):816‐825.

    Not in our library10.1001/jamainternmed.2016.1548

  28. 28.

    Passarelli MN, Newcomb PA, Hampton JM, et al. Cigarette smoking before and after breast cancer diagnosis: Mortality from breast cancer and smoking‐related diseases. J Clin Oncol. 2016;34(12):1315‐1322.

    Not in our library10.1200/jco.2015.63.9328

  29. 29.

    McBride CM, Puleo E, Pollak KI, Clipp EC, Woolford S, Emmons KM. Understanding the role of cancer worry in creating a “teachable moment” for multiple risk factor reduction. Soc Sci Med. 2008;66(3):790‐800.

    Not in our library10.1016/j.socscimed.2007.10.014

  30. 30.

    Leitzmann M, Powers H, Anderson AS, et al. European code against cancer 4th edition: Physical activity and cancer. Cancer Epidemiol. 2015;39:S46‐S55.

    Not in our library10.1016/j.canep.2015.03.009

  31. 31.

    Hudis CA, Jones L. Promoting exercise after a cancer diagnosis: Easier said than done. Br J Cancer. 2014;110(4):829‐830.

    Not in our library10.1038/bjc.2014.12

  32. 32.

    Irwin ML, Crumley D, McTiernan A, et al. Physical activity levels before and after a diagnosis of breast carcinoma. Cancer. 2003;97(7):1746‐1757.

    Not in our library10.1002/cncr.11227

  33. 33.

    de Glas NA, Fontein DBY, Bastiaannet E, et al. Physical activity and survival of postmenopausal, hormone receptor‐positive breast cancer patients: results of the tamoxifen exemestane adjuvant multicenter lifestyle study. Cancer. 2014;120(18):2847‐2854.

    Not in our library10.1002/cncr.28783

  34. 34.

    Song M, Giovannucci E. Preventable incidence and mortality of carcinoma associated with lifestyle factors among white adults in the United States. JAMA Oncol. 2016;2(9):1154‐1161.

    Not in our library10.1001/jamaoncol.2016.0843

  35. 35.

    Courneya KS, McKenzie DC, Reid RD, et al. Barriers to supervised exercise training in a randomized controlled trial of breast cancer patients receiving chemotherapy. Ann Behav Med. 2008;35(1):116‐122.

    Not in our library10.1007/s12160-007-9009-4

  36. 36.

    Irwin ML, Cadmus L, Alvarez‐Reeves M, et al. Recruiting and retaining breast cancer survivors into a randomized controlled exercise trial. Cancer. 2008;112(S11):2593‐2606.

    Not in our library10.1002/cncr.23446

  37. 37.

    Buffart LM, Galvão DA, Brug J, Chinapaw MJM, Newton RU. Evidence‐based physical activity guidelines for cancer survivors: Current guidelines, knowledge gaps and future research directions. Cancer Treat Rev. 2014;40(2):327‐340.

    Not in our library10.1016/j.ctrv.2013.06.007

  38. 38.

    Courneya KS, Friedenreich CM, Quinney HA, et al. A longitudinal study of exercise barriers in colorectal cancer survivors participating in a randomized controlled trial. Ann Behav Med. 2005;29(2):147‐153.

    Not in our library10.1207/s15324796abm2902_9

  39. 39.

    Kushi LH, Doyle C, McCullough M, et al. American Cancer Society guidelines on nutrition and physical activity for cancer prevention. CA Cancer J Clin. 2012;62(1):30‐67.

    Not in our library10.3322/caac.20140

  40. 40.

    Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta‐analyses of studies that evaluate healthcare interventions: Explanation and elaboration. BMJ. 2009;339(jul21 1):b2700‐b2700.

    Not in our library10.1136/bmj.b2700

  41. 41.

    Resolution WHA57.17. Global Strategy on Diet, Physical Activity and Health G. Fifty‐seventh World Health Assembly, World Health Organisation. Resolutions and decisions, annexes, Geneva, 2004.

    Not in our library

  42. 42.

    Caspersen CJ, Powell KE, Christenson GM. Physical activity, exercise, and physical fitness: definitions and distinctions for health‐related research. Public Health Rep. 1985;100(2):126‐131.

    Not in our library

  43. 43.

    Maher CG, Sherrington C, Herbert RD, Moseley AM, Elkins M. Reliability of the PEDro scale for rating quality of randomized controlled trials. Phys Ther. 2003;83(8):713‐721.

    Not in our library

  44. 44.

    Van Peppen R, Kwakkel G, Wood‐Dauphinee S, Hendriks H, Van der Wees P, Dekker J. The impact of physical therapy on functional outcomes after stroke: What's the evidence? Clin Rehabil. 2004;18(8):833‐862.

    Not in our library10.1191/0269215504cr843oa

  45. 45.

    Arem H, Sorkin M, Cartmel B, et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: The hormones and physical exercise (HOPE) study. J Cancer Surviv. 2016;1‐9.

    Not in our library10.1007/s11764-015-0511-6

  46. 46.

    Courneya KS, Segal RJ, Gelmon K, et al. Predictors of adherence to different types and doses of supervised exercise during breast cancer chemotherapy. Int J Behav Nutr Phys Act. 2014;11(1):85.

    Not in our library10.1186/s12966-014-0085-0

  47. 47.

    Courneya KS, Segal RJ, Gelmon K, et al. Predictors of supervised exercise adherence during breast cancer chemotherapy. Med Sci Sport Exerc. 2008;40(6):1180‐1187.

    Not in our library10.1249/mss.0b013e318168da45

  48. 48.

    Courneya KS, Segal RJ, Reid RD, et al. Three independent factors predicted adherence in a randomized controlled trial of resistance exercise training among prostate cancer survivors. J Clin Epidemiol. 2004;57(6):571‐579.

    Not in our library10.1016/j.jclinepi.2003.11.010

  49. 49.

    Shang J, Wenzel J, Krumm S, Griffith K, Stewart K. Who will drop out and who will drop in. Cancer Nurs. 2012;35(4):312‐322.

    Not in our library10.1097/ncc.0b013e318236a3b3

  50. 50.

    McNeely ML, Parliament MB, Seikaly H, et al. Predictors of adherence to an exercise program for shoulder pain and dysfunction in head and neck cancer survivors. Support Care Cancer. 2012;20(3):515‐522.

    Not in our library10.1007/s00520-011-1112-1

  51. 51.

    McGuire R, Waltman N, Zimmerman L. Intervention components promoting adherence to strength training exercise in breast cancer survivors with bone loss. West J Nurs Res. 2011;33(5):671‐689.

    Not in our library10.1177/0193945910379004

  52. 52.

    Kampshoff CS, van Mechelen W, Schep G, et al. Participation in and adherence to physical exercise after completion of primary cancer treatment. Int J Behav Nutr Phys Act. 2016;13(1):100.

    Not in our library10.1186/s12966-016-0425-3

  53. 53.

    Latka RN, Alvarez‐Reeves M, Cadmus L, Irwin ML. Adherence to a randomized controlled trial of aerobic exercise in breast cancer survivors: The Yale exercise and survivorship study. J Cancer Surviv. 2009;3(3):148‐157.

    Not in our library10.1007/s11764-009-0088-z

  54. 54.

    Pinto BM, Rabin C, Dunsiger S. Home‐based exercise among cancer survivors: Adherence and its predictors. Psychooncology. 2009;18(4):369‐376.

    Not in our library10.1002/pon.1465

  55. 55.

    Kuehl R, Schmidt ME, Dreger P, Steindorf K, Bohus M, Wiskemann J. Determinants of exercise adherence and contamination in a randomized controlled trial in cancer patients during and after allogeneic HCT. Support Care Cancer. 2016;24(10):4327‐4337.

    Not in our library10.1007/s00520-016-3271-6

  56. 56.

    Craike M, Gaskin CJ, Courneya KS, et al. Predictors of adherence to a 12‐week exercise program among men treated for prostate cancer: ENGAGE study. Cancer Med. 2016;5(5):787‐794.

    Not in our library10.1002/cam4.639

  57. 57.

    Courneya KS, Stevinson C, McNeely ML, et al. Predictors of adherence to supervised exercise in lymphoma patients participating in a randomized controlled trial. Ann Behav Med. 2010;40(1):30‐39.

    Not in our library10.1007/s12160-010-9205-5

  58. 58.

    Courneya KS, Friedenreich CM, Quinney HA, Fields ALA, Jones LW, Fairey AS. Predictors of adherence and contamination in a randomized trial of exercise in colorectal cancer survivors. Psychooncology. 2004;13(12):857‐866.

    Not in our library10.1002/pon.802

  59. 59.

    Courneya KS, Friedenreich CM, Sela RA, Quinney HA, Rhodes RE. Correlates of adherence and contamination in a randomized controlled trial of exercise in cancer survivors: An application of the theory of planned behavior and the five factor model of personality. Ann Behav Med. 2002;24(4):257‐268.

    Not in our library10.1207/s15324796abm2404_02

  60. 60.

    van Waart H, van Harten WH, Buffart LM, Sonke GS, Stuiver MM, Aaronson NK. Why do patients choose (not) to participate in an exercise trial during adjuvant chemotherapy for breast cancer? Psychooncology. 2016;25(8):964‐970.

    Not in our library10.1002/pon.3936

  61. 61.

    van Dijk‐Lokkart EM, Braam KI, Huisman J, et al. Factors influencing childhood cancer patients to participate in a combined physical and psychosocial intervention program: quality of life in motion. Psychooncology. 2015;24(4):465‐471.

    Not in our library10.1002/pon.3677

  62. 62.

    Hayton C, Clark A, Olive S, et al. Barriers to pulmonary rehabilitation: Characteristics that predict patient attendance and adherence. Respir Med. 2013;107(3):401‐407.

    Not in our library10.1016/j.rmed.2012.11.016

  63. 63.

    Chao D, Foy CG, Farmer D. Exercise adherence among older adults: Challenges and strategies. Control Clin Trials. 2000;21(5):S212‐S217.

    Not in our library10.1016/s0197-2456(00)00081-7

  64. 64.

    Albornoz CR, Cohen WA, Razdan SN, et al. The impact of travel distance on breast reconstruction in the United States. Plast Reconstr Surg. 2016;137(1):12‐18.

    Not in our library10.1097/prs.0000000000001847

  65. 65.

    Bélanger LJ, Plotnikoff RC, Clark A, Courneya KS. A survey of physical activity programming and counseling preferences in young‐adult cancer survivors. Cancer Nurs. 2012;35(1):48‐54.

    Not in our library10.1097/ncc.0b013e318210220a

  66. 66.

    Trinh L, Plotnikoff RC, Rhodes RE, North S, Courneya KS. Physical activity preferences in a population‐based sample of kidney cancer survivors. Support Care Cancer. 2012;20(8):1709‐1717.

    Not in our library10.1007/s00520-011-1264-z

  67. 67.

    Pastakia K, Kumar S. Exercise parameters in the management of breast cancer: A systematic review of randomized controlled trials. Physiother Res Int. 2011;16(4):237‐244.

    Not in our library10.1002/pri.505

  68. 68.

    Coughlin SS, Whitehead M, Sheats JQ, Mastrominico J, Smith S. A review of smartphone applications for promoting physical activity. Jacobs J Community Med. 2016;2(1):1‐14.

    Not in our library

  69. 69.

    Husebø AML, Dyrstad SM, Søreide JA, Bru E. Predicting exercise adherence in cancer patients and survivors: A systematic review and meta‐analysis of motivational and behavioural factors. J Clin Nurs. 2013;22(4):4‐21.

    Not in our library10.1111/j.1365-2702.2012.04322.x

  70. 70.

    Prochaska JO, DiClemente CC. Stages and processes of self‐change of smoking: Toward an integrative model of change. J Consult Clin Psychol. 1983;51(3):390‐395.

    Not in our library10.1037//0022-006x.51.3.390

  71. 71.

    Marshall SJ, Biddle SJ. The transtheoretical model of behavior change: a meta‐analysis of applications to physical activity and exercise. Ann Behav Med. 2001;23(4):229‐246.

    Not in our library10.1207/s15324796abm2304_2

  72. 72.

    Lahham A, Mcdonald CF, Holland AE. Exercise training alone or with the addition of activity counseling improves physical activity levels in COPD: A systematic review and meta‐analysis of randomized controlled trials. 2016;11(1):3121‐3136.

    Not in our library10.2147/copd.s121263

  73. 73.

    Aguiar EJ, Morgan PJ, Collins CE, Plotnikoff RC, Callister R. Efficacy of interventions that include diet, aerobic and resistance training components for type 2 diabetes prevention: a systematic review with meta‐analysis. Int J Behav Nutr Phys Act. 2014;11:2.

    Not in our library10.1186/1479-5868-11-2

  74. 74.

    Buffart LM, Kalter J, Sweegers MG, et al. Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta‐analysis of 34 RCTs. Cancer Treat Rev. 2017;52:91‐104.

    Not in our library10.1016/j.ctrv.2016.11.010

  75. 75.
  76. 76.

    Deeks JJ, Dinnes J, D'Amico R, et al. Evaluating non‐randomised intervention studies. Health Technol Assess. 2003;7(27):1‐173.

    Not in our library10.3310/hta7270

  77. 77.

    Rock CL, Flatt SW, Byers TE, et al. Results of the Exercise and Nutrition to Enhance Recovery and Good health for You (ENERGY) trial: A behavioral weight loss intervention in overweight or obese breast cancer survivors. J Clin Oncol. 2015;33(28):3169‐3176.

    Not in our library10.1200/jco.2015.61.1095

  78. 78.

    Middleton KMR, Patidar SM, Perri MG. The impact of extended care on the long‐term maintenance of weight loss: A systematic review and meta‐analysis. Obes Rev. 2012;13(6):509‐517.

    Not in our library10.1111/j.1467-789x.2011.00972.x

Cited by papers we hold 4

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.